As the spring conference season winds down, there was one topic that remained top of mind. At the Food and Drug Law Institute (“FDLI”)’s Annual Conference on May 17-18, 2023, the U.S..
At FDLI Conference, DOJ CPB and FDA continued discussing new Voluntary Self Disclosure Policy for Business Organizations to support more transparency for companies deciding whether to self disclose misconduct.
Global Investigations Review (GIR) is the hub for global coverage of corporate investigations and their aftermath. Keep up to date with significant developments in the corporate investigations world.